Advertisement
UK markets open in 1 hour 32 minutes
  • NIKKEI 225

    39,088.38
    +283.73 (+0.73%)
     
  • HANG SENG

    18,109.31
    +81.60 (+0.45%)
     
  • CRUDE OIL

    81.68
    +0.05 (+0.06%)
     
  • GOLD FUTURES

    2,339.80
    -4.60 (-0.20%)
     
  • DOW

    39,411.21
    +260.88 (+0.67%)
     
  • Bitcoin GBP

    48,301.57
    -900.96 (-1.83%)
     
  • CMC Crypto 200

    1,273.63
    -36.09 (-2.76%)
     
  • NASDAQ Composite

    17,496.82
    -192.54 (-1.09%)
     
  • UK FTSE All Share

    4,514.76
    +23.84 (+0.53%)
     

Mirion Announces Updated Time of Presentation at Jefferies’ 2024 Global Healthcare Conference

ATLANTA, June 04, 2024--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that its management team’s presentation at Jefferies’ 2024 Global Healthcare Conference will now begin at 3:30 PM ET on Thursday, June 6, 2024.

The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations" section. An archive of the webcast will be available at the same location within twelve hours of the conclusion of the event.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240604787612/en/

Contacts

For investor inquiries, please contact:

Jerry Estes
ir@mirion.com